Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy

Abstract excerpt

The majority of phase I- and phase II-dependent drug metabolism is carried out by polymorphic enzymes which can cause abolished, quantitatively or qualitatively decreased or enhanced drug metabolism. Several examples exist where subjects carrying certain alleles do not benefit from drug therapy due to ultrarapid metabolism caused by multiple genes or by induction of gene expression or, alternatively, suffer from...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Transport and Resistance Mechanisms
• Share to Metabolism and Genetic Disorders
• Share to Pharmacogenetics and Drug Metabolism